Clinical severity of Alzheimer's disease is associated with PIB uptake in PET

被引:68
作者
Grimmer, Timo [1 ]
Henriksen, Gjermund [2 ]
Wester, Hans-Juergen [2 ]
Foerstl, Hans
Klunk, William E. [3 ]
Mathis, Chester A. [4 ]
Kurz, Alexander
Drzezga, Alexander [2 ]
机构
[1] Tech Univ Munich, Klinikum Rechts Isar, Klin & Poliklin Psychiat & Psychotherapie, Dept Psychiat & Psychotherapy, D-81675 Munich, Germany
[2] Tech Univ Munich, Klinikum Rechts Isar, Dept Nucl Med, D-81675 Munich, Germany
[3] Western Psychiat Inst & Clin, Dept Psychiat, Pittsburgh, PA 15213 USA
[4] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15213 USA
关键词
Alzheimer's disease; Dementia; Clinical Dementia Rating; Amyloid plaques; Positron emission tomography; Imaging; 18F]FDG; 11C]PIB; Pittsburgh Compound B; CEREBRAL GLUCOSE-METABOLISM; PITTSBURGH COMPOUND-B; AMYLOID DEPOSITION; DEMENTIA; PLAQUES; BRAIN; AD; NEUROPATHOLOGY; DIAGNOSIS; CRITERIA;
D O I
10.1016/j.neurobiolaging.2008.01.016
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background: The positron emission tomography (PET) tracer [11C]-Pittsburgh Compound-B ([11C]PIB) allows the in vivo assessment of amyloid plaque burden in the brain. In a cross-sectional study we examined the association between the seventy of dementia assessed using the Clinical Dementia Rating scale sum of boxes (CDR-SOB) and [11C]PIB-PET in patients with Alzheimer's disease (AD). Methods: Patients with probable AD who had an AD-typical [18F]FDG-PET scan were included Linear regression analysis in anatomically defined regions-of-interest (ROIs) and correlation analysis using statistical parametric mapping (SPM) were used to determine the association between CDR-SOB and [11C]PIB uptake. Results: The linear regression analyses showed that the CDR-SOB explained approximately 11-22% of the variance of [11C]PIB uptake. The association attained statistical significance in both frontal, in both anterior cingulate cortices, and in both putamina. The SPM analysis showed a significant association in more widespread regions of the brain, with maxima located in similar areas as in the ROI-analysis. Conclusion: The CDR-SOB score is significantly associated with [11C]PIB uptake in patients with AD Thus [11C]PIB is a potential surrogate marker of dementia severity. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:1902 / 1909
页数:8
相关论文
共 50 条
  • [21] PET/CT/MRI in Clinical Trials of Alzheimer's Disease
    Hoilund-Carlsen, Poul F.
    Alavi, Abass
    Barrio, Jorge R.
    JOURNAL OF ALZHEIMERS DISEASE, 2024, 101 : S579 - S601
  • [22] Sleep Dysregulation Is Associated with 18F-FDG PET and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease
    Fernandes, Mariana
    Chiaravalloti, Agostino
    Nuccetelli, Marzia
    Placidi, Fabio
    Izzi, Francesca
    Camedda, Riccardo
    Bernardini, Sergio
    Sancesario, Giuseppe
    Schillaci, Orazio
    Mercuri, Nicola Biagio
    Liguori, Claudio
    JOURNAL OF ALZHEIMERS DISEASE REPORTS, 2023, 7 (01) : 845 - 854
  • [23] Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer's disease
    Villemagne, Victor L.
    Mulligan, Rachel S.
    Pejoska, Svetlana
    Ong, Kevin
    Jones, Gareth
    O'Keefe, Graeme
    Chan, J. Gordon
    Young, Kenneth
    Tochon-Danguy, Henri
    Masters, Colin L.
    Rowe, Christopher C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 (06) : 983 - 989
  • [24] In vivo imaging of astrocytosis in Alzheimer’s disease: an 11C-L-deuteriodeprenyl and PIB PET study
    Alexander Frizell Santillo
    Juan Pablo Gambini
    Lars Lannfelt
    Bengt Långström
    Luohija Ulla-Marja
    Lena Kilander
    Henry Engler
    European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38 : 2202 - 2208
  • [25] A European multicentre PET study of fibrillar amyloid in Alzheimer's disease
    Nordberg, Agneta
    Carter, Stephen F.
    Rinne, Juha
    Drzezga, Alexander
    Brooks, David J.
    Vandenberghe, Rik
    Perani, Daniela
    Forsberg, Anton
    Langstrom, Bengt
    Scheinin, Noora
    Karrasch, Mira
    Nagren, Kjell
    Grimmer, Timo
    Miederer, Isabelle
    Edison, Paul
    Okello, Aren
    Van Laere, Koen
    Nelissen, Natalie
    Vandenbulcke, Mathieu
    Garibotto, Valentina
    Almkvist, Ove
    Kalbe, Elke
    Hinz, Rainer
    Herholz, Karl
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (01) : 104 - 114
  • [26] Alzheimer's disease: nutritional status and cognitive aspects associated with disease severity
    Nascimento dos Santos, Tamires Barbosa
    Fonseca, Lineu Correa
    de Almeida Souza Tedrus, Gloria Maria
    Delbue Bernardi, Julia Laura
    NUTRICION HOSPITALARIA, 2018, 35 (06) : 1298 - 1304
  • [27] Tau-PET imaging as a molecular modality for Alzheimer's disease
    Ayubcha, Cyrus
    Rigney, Grant
    Borja, Austin J.
    Werner, Thomas
    Alavi, Abass
    AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 11 (05): : 374 - 386
  • [28] [11C]PIB-, [18F]FDG-PET and MRI imaging in patients with Parkinson's disease with and without dementia
    Jokinen, Pekka
    Scheinin, Noora
    Aalto, Sargo
    Nagren, Kjell
    Savisto, Nina
    Parkkola, Riitta
    Rokka, Johanna
    Haaparanta, Merja
    Roytta, Matias
    Rinne, Juha O.
    PARKINSONISM & RELATED DISORDERS, 2010, 16 (10) : 666 - 670
  • [29] Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG
    Shin, Jonghan
    Lee, Sang-Yoon
    Kim, Seog Ju
    Kim, So-Hee
    Cho, Seong-Jin
    Kim, Young-Bo
    NEUROIMAGE, 2010, 52 (02) : 488 - 496
  • [30] 11C-PIB PET imaging reveals that amyloid deposition in cases with early-onset Alzheimer's disease in the absence of known mutations retains higher levels of PIB in the basal ganglia
    Youn, Young Chul
    Jang, Jae-Won
    Han, Su-Hyun
    Kim, HyeRyoun
    Seok, Ju-Won
    Byun, Jun Soo
    Park, Kwang-Yeol
    An, Seong Soo A.
    Chun, In Kook
    Kim, Sangyun
    CLINICAL INTERVENTIONS IN AGING, 2017, 12 : 1041 - 1048